5.0
19. Feb. 2014
Aktueller Mitarbeiter, mehr als 5 Jahre
South San Francisco, CA
Empfehlen
CEO-Befürwortung
Geschäftsprognose
Pros
Casual Intensity. Focus on Patients. Following the Science. Genentech is also a member of the Roche Group which gives it a global reach. Exciting to be expanding into China and Latin America.
Kontras
At times too functionally siloed. Not convinced having too separate Research and Early Development organizations is economically prudent.